Welcome to SlieaGen!
Enhancing the Quality of Human Life Through Commercial Biotechnical Research
Successfully Completed CDC Inspection: July, 2020
SlieaGen is a clinical research organization and biorepository
for thousands of biological specimens of worldwide infectious and non-infectious diseases.
While adhering to stringent IRB/IEC approved protocols and guidelines,
SlieaGen offers access to a diverse multitude of patient consented specimens.
Our foremost goal is to achieve total customer satisfaction by providing high-quality
biospecimens and to offer our meticulous collection standards to successfully assist
in all of your research and clinical needs.
What We Do
SlieaGen offers high quality specimens and clinical services to In-vitro Diagnostic, Biotechnology and Pharmaceutical industries.
With its network of efficient global principal investigators and clinical resources, SlieaGen is able to bring the products under trial to the market faster than its competitors.
Comprehensive Clinical Services
Design of Collection Protocols
compliant informed consents
How We Do It
Our Quality Standards are based on the industry’s best clinical practices with strict adherence to regulatory standards.
We strive to provide the highest level of customer service to satisfy our client expectations and go to great lengths (occasionally very remote areas) to find the solution to our client's specimen requirements.
High Quality Specimens and Services
With a proven track record in the collection of difficult to source samples, we exceed our client’s requirements for high-quality specimens and services.
Our experienced team of well-trained professionals and unparalleled industry experts, work diligently to maintain a well-established Quality System employing Continuous Improvement (Kaizen) that enables us to efficiently & effectively partner with our clients and contribute to the path of disease eradication.
Research and Planning with Integrity
Protecting the welfare and privacy of Donors is our top priority. Towards that end, we:
Operate under a CDC Import Permit for a substantial array of bacterial, fungal, viral and parasitic specimens
Collect all specimens under IRB/IEC/MOH approved protocols with patient consent
Operate under a Quality System compliant with FDA regulations, ISO 9001:2015 standards, current Good Clinical Practice (cGCP), current Good Laboratory Practice (cGLP) and industry best practices
Current IRB/IEC approvals in 23 different countries and growing
LABORATORY & LOGISTICS
SlieaGen maintains the facility and staff to guarantee that our research partners will get the specimens they request – on time with no loss in sample integrity.
Biosafety Level 2 facility.
Experienced, well-trained staff.
Established Quality System procedures compliant with current Good Laboratory Practices.
Secure, on-demand access to data through a protected web portal.
Biorespository containing over 8,000 unique subjects.
Barcoded inventory for specimen identification and traceability.
24-hour security surveillance.
Keeping pace with industry needs and specifications, we offer:
Secure storage of thousands of whole blood, serum, plasma,
urine, sputum or tissue samples.
Calibrated and well-maintained equipment; frozen storage for both -20 degree C & -80 degree C requirements.
Temperature Guard System for continuous monitoring of freezers with remote alarm notification capability.
Storage for specimens required to be maintained at temperatures between 2-8 degrees C.
Understanding our client’s specifications, we work closely in conjunction with their needs to ensure that the samples are not compromised and are delivered on time, every time.
We utilize the services of FedEx, DHL, Schenker, World Courier and Ocean Air for rapid domestic and international shipments with a punctual delivery.
Strict adherence to IATA and DOT regulations.
Testing services are provided by certified Reference Laboratories, Academic and Hospital research facilities and in-house testing at SlieaGen.
FDA approved assays when available, CE approved and Laboratory Developed Tests with validated methodologies.
DNA/RNA quantification or qualification.
Serology including IgM, IgG and antigen testing.
Genotype and Subtype by sequencing (for selected disease state samples).